Connect with us

Wellness

One in five taking part in Dry January turn to cannabis instead – survey

In a US survey, 21% of those polled said they were consuming cannabis-based products this month.

Published

on

21% of Dry January participants said they were turning to cannabis-based products this month.

One in five people taking part in Dry January are substituting alcohol for cannabis, a new survey from the US shows. 

Dry January has become increasingly popular in recent years, as consumers attempt to ditch the drink throughout the first month of the year, following the boozy festive period.

According to the charity, Alcohol Change UK, the official Dry January programme is the result of one woman deciding to quit drinking to prepare for a half-marathon and experiencing almost immediate health benefits including increased energy, better sleep and weight loss. 

The campaign began with 4,000 participants in 2013, growing to an estimated 130,000 people in 2022.

The challenge has also spread overseas, with a recent survey showing that almost half (41%) of US alcohol drinkers polled were considering quitting alcohol during January 2023, with those aged 21-34 most likely to do so.

The latest data, from US polling platform Civic Science, shows that among those who have taken on the challenge, a considerable number are turning to alternatives –  including cannabis – to fill the gap.

Roughly 60% of those partaking in Dry January are turning to substitutes including non-alcoholic beverages, cannabis/CBD products and soda/seltzer products. 

Cannabis was the most popular alternative, with 21% saying they were consuming to cannabis-based products this month, followed by non-alcoholic beverages (20%), soda and seltzer (20%) and kombucha (6%).

Those in the younger age group (21-24 years) were most likely to consume cannabis, with 34% saying this was their preferred alternative, compared to 24% of those aged 25-34, 22% of 35-54-year-olds and just 9% of those aged 55 and older.

Changing attitudes towards alcohol and cannabis 

The findings won’t come as much of a surprise to many, with cannabis increasingly becoming a preferred method for switching off at the end of the week, especially among younger generations. 

A 2022 survey carried out by New Frontier suggests that two-thirds of US-based consumers aged between 18 and 44 (Gen-Z and millennials) prefer cannabis to alcohol, and more than half of the same age group are replacing (at least some of) their alcohol use with cannabis.

Research also shows that when medical cannabis became legal in Canada, alcohol sales decreased, indicating that people were substituting cannabis for alcohol. Elsewhere US states which have legalised cannabis were found to have lower rates of alcohol use disorder. 

While there are always risks when it comes to consuming any substance, cannabis is increasingly becoming thought of as a safer – and potentially healthier – alternative to alcohol.

Home » Lifestyle » Wellness » One in five taking part in Dry January turn to cannabis instead – survey

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.